Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion type Assertion NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_head.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion description "[Of the Th1-like PTCL studied, 33 of 42 (79%) were immunoreactive for LEF-1 and 32 of 42 (76%) were immunoreactive for TCF-1, including most cases of angioimmunoblastic lymphoma and all cases of lymphoepithelioid lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_provenance.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion evidence source_evidence_literature NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_provenance.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion SIO_000772 12707037 NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_provenance.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion wasDerivedFrom befree-20150227 NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_provenance.
- NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_assertion wasGeneratedBy ECO_0000203 NP902824.RATgCH3PW83z7vN-CLtmsFxFhk9zQ9h3Qi34TuIr1SDls130_provenance.